Cornercap Investment Counsel Inc Tenaya Therapeutics, Inc. Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 64,563 shares of TNYA stock, worth $187,878. This represents 0.05% of its overall portfolio holdings.
Number of Shares
64,563
Previous 81,255
20.54%
Holding current value
$187,878
Previous $263,000
28.14%
% of portfolio
0.05%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding TNYA
# of Institutions
90Shares Held
47.2MCall Options Held
35.8KPut Options Held
1.1K-
Column Group LLC San Francisco, CA9.4MShares$27.4 Million30.64% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$19.6 Million2.84% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$13.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.35MShares$9.74 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.86MShares$8.33 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $120M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...